[Angioedema and urticarial reaction induced by valsartan].
de la Serna Higuera
C
C
D000799:Angioedema / Q000139:chemically induced* / Q000188:drug therapy; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000009:adverse effects*; D000982:Antipruritics / Q000627:therapeutic use; D003875:Drug Eruptions / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D005500:Follow-Up Studies; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D017336:Loratadine / Q000627:therapeutic use; D008875:Middle Aged; D013777:Tetrazoles / Q000009:adverse effects*; D013997:Time Factors; D014581:Urticaria / Q000139:chemically induced* / Q000188:drug therapy; D014633:Valine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000068756:Valsartan
D018926:Anti-Allergic Agents; D000959:Antihypertensive Agents; D000982:Antipruritics; D006634:Histamine H1 Antagonists; D013777:Tetrazoles; D017336:Loratadine; D000068756:Valsartan; D014633:Valine